Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 54 Records) |
| Query Trace: Cholangiocarcinoma and IDH1[original query] |
|---|
| Association of TP53 Alteration with Tissue Specificity and Patient Outcome of IDH1-Mutant Glioma. Cells 2021 8 10 (8): . Murnyak Balazs, Huang L Er |
| Comparative Genomic Analysis of Intrahepatic Cholangiocarcinoma: Biopsy Type, Ancestry, and Testing Patterns. The oncologist 2021 Jun . Israel Mason A, Danziger Natalie, McGregor Kimberly A, Murugesan Karthikeyan, Gjoerup Ole, Sokol Ethan S, Tukachinsky Hanna, Kurzrock Razelle, Kato Shumei, Sicklick Jason K, Nimeiri Halla S, Oxnard Geoffrey R, Ross Jeffrey |
| Benchmarking Outcomes after Ablative Radiotherapy for Molecularly Characterized Intrahepatic Cholangiocarcinoma. Journal of personalized medicine 2021 12 11 (12): . De Brian, Abu-Gheida Ibrahim, Patel Aashini, Ng Sylvia S W, Zaid Mohamed, Thunshelle Connor P, Elganainy Dalia, Corrigan Kelsey L, Rooney Michael K, Javle Milind, Raghav Kanwal, Lee Sunyoung S, Vauthey Jean-Nicolas, Tzeng Ching-Wei D, Tran Cao Hop S, Ludmir Ethan B, Minsky Bruce D, Smith Grace L, Holliday Emma B, Taniguchi Cullen M, Koong Albert C, Das Prajnan, Koay Eugene |
| Epigenetic upregulation of TET2 is an independent poor prognostic factor for intrahepatic cholangiocarcinoma. Virchows Archiv : an international journal of pathology 2021 12 480 (5): 1077-1085. Yamashita Hironori, Tourna Aikaterini, Akita Masayuki, Itoh Tomoo, Chokshi Shilpa, Ajiki Tetsuo, Fukumoto Takumi, Youngson Neil A, Zen Y |
| Ivosidenib Boosts OS in Cholangiocarcinoma. Cancer discovery 2021 10 11 (12): 2953-2954. Authors are not available |
| Effect of comprehensive cancer genomic profiling on therapeutic strategies and clinical outcomes in patients with advanced biliary tract cancer: A prospective multicenter study. Frontiers in oncology 2022 9 12 988527. Takada Kohichi, Kubo Tomohiro, Kikuchi Junko, Yoshida Makoto, Murota Ayako, Arihara Yohei, Nakamura Hajime, Nagashima Hiroyuki, Tanabe Hiroki, Sugita Shintaro, Tanaka Yumi, Miura Ayana, Ohhara Yoshihito, Ishiguro Atsushi, Yokouchi Hiroshi, Kawamoto Yasuyuki, Mizukami Yusuke, Ohnishi Hirofumi, Kinoshita Ichiro, Sakurai Akihi |
| Real-World Data on Ivosidenib in Patients with Previously Treated Isocitrate Dehydrogenase 1-Mutated Intrahepatic Cholangiocarcinomas: An Early Exploratory Analysis. Targeted oncology 2022 Sep 17 (5): 591-596. Rimini Margherita, Burgio Valentina, Antonuzzo Lorenzo, Rimassa Lorenza, Oneda Ester, Lavacchi Daniele, Personeni Nicola, Ratti Francesca, Pedica Federica, Della Corte Angelo, Persano Mara, De Cobelli Francesco, Aldrighetti Luca, Scartozzi Mario, Cascinu Stefano, Casadei-Gardini Andr |
| Molecular characterization-based multi-omics analyses in primary liver cancer using the Japanese version of the genome atlas. Journal of hepato-biliary-pancreatic sciences 2022 8 . Imamura Taisuke, Okamura Yukiyasu, Ohshima Keiichi, Uesaka Katsuhiko, Sugiura Teiichi, Yamamoto Yusuke, Ashida Ryo, Ohgi Katsuhisa, Nagashima Takeshi, Yamaguchi K |
| Ferroptosis in Intrahepatic Cholangiocarcinoma: IDH1 Single Nucleotide Polymorphism Is Associated With Its Activation and Better Prognosis. Frontiers in medicine 2022 7 9 886229. Sarcognato Samantha, Sacchi Diana, Fabris Luca, Zanus Giacomo, Gringeri Enrico, Niero Monia, Gallina Giovanna, Guido Mar |
| Clinical, Genomic, and Transcriptomic Data Profiling of Biliary Tract Cancer Reveals Subtype-Specific Immune Signatures. JCO precision oncology 2022 6 6 e2100510. Mody Kabir, Jain Prerna, El-Refai Sherif M, Azad Nilofer S, Zabransky Daniel J, Baretti Marina, Shroff Rachna T, Kelley R Katie, El-Khouiery Anthony B, Hockenberry Adam J, Lau Denise, Lesinski Gregory B, Yarchoan Ma |
| Cell-Free Tumor DNA Dominant Clone Allele Frequency Is Associated With Poor Outcomes in Advanced Biliary Cancers Treated With Platinum-Based Chemotherapy. JCO precision oncology 2022 Jun 6 e2100274. Uson Junior Pedro Luiz Serrano, Majeed Umair, Yin Jun, Botrus Gehan, Sonbol Mohamad Bassam, Ahn Daniel H, Starr Jason S, Jones Jeremy C, Babiker Hani, Inabinett Samantha R, Wylie Natasha, Boyle Ashton W R, Bekaii-Saab Tanios S, Gores Gregory J, Smoot Rory, Barrett Michael, Nagalo Bolni, Meurice Nathalie, Elliott Natalie, Petit Joachim, Zhou Yumei, Arora Mansi, Dumbauld Chelsae, Barro Oumar, Baker Alexander, Bogenberger James, Buetow Kenneth, Mansfield Aaron, Mody Kabir, Borad Mitesh |
| FDA Approval Summary: Ivosidenib for the Treatment of Patients with Advanced Unresectable or Metastatic, Chemotherapy Refractory Cholangiocarcinoma with an IDH1 Mutation. Clinical cancer research : an official journal of the American Association for Cancer Research 2022 3 28 (13): 2733-2737. Casak Sandra J, Pradhan Shan, Fashoyin-Aje Lola A, Ren Yi, Shen Yuan-Li, Xu Yuan, Chow Edwin Chiu Yuen, Xiong Ye, Zirklelbach Jeanne Fourie, Liu Jiang, Charlab Rosane, Pierce William F, Fesenko Nataliya, Beaver Julia A, Pazdur Richard, Kluetz Paul G, Lemery Steven |
| Pan-tumor landscape of fibroblast growth factor receptor 1-4 genomic alterations. ESMO open 2022 12 7 (6): 100641. Murugesan K, Necchi A, Burn T C, Gjoerup O, Greenstein R, Krook M, López J A, Montesion M, Nimeiri H, Parikh A R, Roychowdhury S, Schwemmers S, Silverman I M, Vogel |
| Next-generation sequencing analysis of cholangiocarcinoma identifies distinct IDH1-mutated clusters. European journal of cancer (Oxford, England : 1990) 2022 Sep 175 299-310. Rimini Margherita, Loi Eleonora, Fabregat-Franco Carles, Burgio Valentina, Lonardi Sara, Niger Monica, Scartozzi Mario, Raposelli Ilario G, Aprile Giuseppe, Ratti Francesca, Pedica Federica, Verdaguer Helena, Rizzato Mario, Nichetti Federico, Lai Eleonora, Cappetta Alessandro, Macarulla Teresa, Fassan Matteo, De Braud Filippo, Pretta Andrea, Simionato Francesca, De Cobelli Francesco, Aldrighetti Luca, Fornaro Lorenzo, Cascinu Stefano, Zavattari Patrizia, Casadei-Gardini Andr |
| Circulating Cell-Free DNA-Based Comprehensive Molecular Analysis of Biliary Tract Cancers Using Next-Generation Sequencing. Cancers 2022 1 14 (1): . Csoma Szilvia Lilla, Bedekovics Judit, Veres Gerg?, Árokszállási Anita, András Csilla, Méhes Gábor, Mokánszki Atti |
| Platinum sensitivity in patients with IDH1/2 mutated versus wild-type intrahepatic cholangiocarcinoma: a propensity score-based study. International journal of cancer 2022 Jun . Niger Monica, Nichetti Federico, Casadei-Gardini Andrea, Rizzato Mario Domenico, Pircher Chiara, Bini Marta, Franza Andrea, Rimini Margherita, Burgio Valentina, Sposetti Caterina, Fornaro Lorenzo, Rapposelli Ilario Giovanni, D'Amico Francesco Enrico, Aprile Giuseppe, Vivaldi Caterina, Frassineti Giovanni Luca, Milione Massimo, Leoncini Giuseppe, Cappetta Alessandro, Vasile Enrico, Fassan Matteo, Morano Federica, Perrone Federica, Tamborini Elena, Pruneri Giancarlo, Lonardi Sara, Mazzaferro Vincenzo, Pietrantonio Filippo, Di Bartolomeo Maria, de Braud Filip |
| Comparative Genomic Analysis and Clinical Outcomes of BRAF-mutated Advanced Biliary Tract Cancers. Clinical cancer research : an official journal of the American Association for Cancer Research 2023 9 . Tin-Yun Tang, Federico Nichetti, Benjamin Kaplan, Sara Lonardi, Filippo Pietrantonio, Lisa Salvatore, Caterina Vivaldi, Lorenza Rimassa, Filippo de Braud, Mario Domenico Rizzato, Dean Pavlick, Randy Chu, Anaemy Danner De Armas, Radwa Sharaf, Ethan Sokol, Jordi Rodon Ahnert, Jeffrey S Ross, Milind Javle, Monica Nig |
| Comprehensive analyses of the clinicopathological features and genomic mutations of combined hepatocellular-cholangiocarcinoma. Hepatology research : the official journal of the Japan Society of Hepatology 2023 9 . Takashi Ito, Takamichi Ishii, Haruhiko Takeda, Shinji Sumiyoshi, Katsuhiro Tomofuji, Satoshi Wakama, Kenta Makino, Hiroshi Horie, Ken Kumagai, Atsushi Takai, Elena Yukie Uebayashi, Satoshi Ogiso, Ken Fukumitsu, Hironori Haga, Hiroshi Seno, Etsuro Hata |
| Platinum Sensitivity in IDH1/2 mutated Intrahepatic Cholangiocarcinoma: Not all "BRCAness" is Created Equal. Cancer investigation 2023 7 1-11. Deborah Blythe Doroshow, Wei Wei, Meenakshi Mehrotra, Daniella Sia, Joseph Paul Eder, Ranjit Bindra, Jane Houldsworth, Patricia LoRusso, Zenta Walth |
| Updated survival outcomes with ivosidenib in patients with previously treated IDH1-mutated intrahepatic-cholangiocarcinoma: an Italian real-world experience. Therapeutic advances in medical oncology 2023 7 15 17588359231171574. Margherita Rimini, Valentina Burgio, Lorenzo Antonuzzo, Lorenza Rimassa, Ester Oneda, Caterina Soldà, Pasqua Cito, Guglielmo Nasti, Daniele Lavacchi, Valentina Zanuso, Mario Domenico Rizzato, Alberto Zaniboni, Alessandro Ottaiano, Mara Persano, Noemi Cornara, Mario Scartozzi, Stefano Cascinu, Andrea Casadei-Gardi |
| Therapeutic yield of extensive molecular profiling in cholangiocarcinoma: a retrospective single-center study. Journal of cancer research and clinical oncology 2023 5 . Justine Vancanneyt, Bie Wilmsen, Caroline Luyten, Chris Verslype, Eric Van Cutsem, Tania Roskams, Sabine Tejpar, Isabelle Vanden Bempt, Jeroen Dekerv |
| Real-world cohort study of PD-1 blockade plus lenvatinib for advanced intrahepatic cholangiocarcinoma: effectiveness, safety, and biomarker analysis. Cancer immunology, immunotherapy : CII 2023 10 . Jiashuo Chao, Shanshan Wang, Hao Wang, Nan Zhang, Yunchao Wang, Xu Yang, Chengpei Zhu, Cong Ning, Xinmu Zhang, Jingnan Xue, Longhao Zhang, Mingjian Piao, Mingming Wang, Xiaobo Yang, Ling Lu, Haitao Zh |
| Clinical Outcomes After Progression on First-Line Therapies in IDH1 Mutated Versus Wild-Type Intrahepatic Cholangiocarcinoma Patients. Targeted oncology 2023 1 18 (1): 139-145. Rimini Margherita, Fabregat-Franco Carles, Persano Mara, Burgio Valentina, Bergamo Francesca, Niger Monica, Scartozzi Mario, Rapposelli Ilario Giovanni, Aprile Giuseppe, Ratti Francesca, Pedica Federica, Verdaguer Helena, Rizzato Mario, Nichetti Federico, Lai Eleonora, Cappetta Alessandro, Macarulla Teresa, Fassan Matteo, De Braud Filippo, Pretta Andrea, Simionato Francesca, De Cobelli Francesco, Aldrighetti Luca, Fornaro Lorenzo, Cascinu Stefano, Casadei-Gardini Andr |
| Racial and Sex Differences in Genomic Profiling of Intrahepatic Cholangiocarcinoma. Annals of surgical oncology 2024 9 . Diamantis I Tsilimigras, Hunter Stecko, Ioannis Ntanasis-Stathopoulos, Timothy M Pawl |
| KRAS Allelic Variants in Biliary Tract Cancers. JAMA network open 2024 5 7 (5): e249840. Gordon Taylor Moffat, Zishuo Ian Hu, Funda Meric-Bernstam, Elisabeth Kathleen Kong, Dean Pavlick, Jeffrey S Ross, Karthikeyan Murugesan, Lawrence Kwong, Anaemy Danner De Armas, Anil Korkut, Milind Javle, Jennifer J Kn |
| [Molecular pathology of gastrointestinal neoplasms]. Magyar onkologia 2024 12 68 (4): 325. Tamás Strausz, László Báthory-Fülöp, Eszter Papp, Erika Tó |
| Impact of genetic alterations on long-term outcomes in resectable intrahepatic cholangiocarcinoma: meta-analysis. The British journal of surgery 2024 11 111 (11): . Fabio Giannone, Fabio Del Zompo, Antonio Saviano, Erwan Pencreach, Catherine Schuster, Thomas F Baumert, Patrick Pessa |
| Concordance of ctDNA and tissue genomic profiling in advanced biliary tract cancer. Journal of hepatology 2024 10 . Sohyun Hwang, Seonjeong Woo, Beodeul Kang, Haeyoun Kang, Jung Sun Kim, Sung Hwan Lee, Chang Il Kwon, Dong Soo Kyung, Hwang-Phill Kim, Gwangil Kim, Chan Kim, Hong Jae Ch |
| Molecular profiling of biliary tract cancers reveals distinct genomic landscapes between circulating and tissue tumor DNA. Experimental hematology & oncology 2024 1 13 (1): 2. Clémence Astier, Carine Ngo, Léo Colmet-Daage, Virginie Marty, Olivia Bawa, Claudio Nicotra, Maud Ngo-Camus, Antoine Italiano, Christophe Massard, Jean-Yves Scoazec, Cristina Smolenschi, Michel Ducreux, Antoine Hollebecque, Sophie Postel-Vin |
| Molecular Profiling of Biliary Tract Cancers in African American and Caucasian Patients. JCO precision oncology 2025 1 9 e2400712. Zishuo Ian Hu, Dean C Pavlick, Jeffrey S Ross, Sunyoung S Lee, Madhulika Eluri, Milind Jav |
- Page last reviewed:Feb 1, 2024
- Content source: